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Conclusions. Blood pressure levels and proteinuria did not ac-Hypertensive nephrosclerosis in African Americans versus
count for morphological lesions, suggesting other factors (suchCaucasians.
as genetic factors, microvascular disease) may play a role. TheBackground. Extensive global glomerulosclerosis (GS) has
phenotype of GS differs in biopsied African Americans versusbeen reported in African Americans with hypertension and
Caucasians with hypertensive nephrosclerosis, with a markedrenal insufficiency, far exceeding that in Caucasians. To as-
increase in the solidified form of GS in African Americans. Thesess and compare severity and phenotype of injury in biopsied
association of extensive solidified GS with segmental sclerosisAfrican Americans and Caucasians who morphologically had
lesions in African Americans, but not in Caucasians, suggestshypertensive nephrosclerosis, we performed a retrospective
different mechanisms may contribute to the development andbiopsy study.
progression of sclerosis in these two patient groups.Methods. All renal biopsies with a histological diagnosis of
hypertensive nephrosclerosis from the last 11 years were identi-
fied from our clinical files. Lesions of global and segmental
sclerosis, interstitial fibrosis and vascular sclerosis were semi- Hypertensive nephrosclerosis is considered one of thequantitatively analyzed as percent involved, or on a 0 to 3 scale,
most common causes of end-stage renal disease (ESRD),respectively. The phenotypes of global glomerulosclerosis also
as reported in all national registries both in Europe andwere categorized as either the solidified (that is, the entire tuft
is solidified) or the obsolescent type (that is, Bowman’s space in USA [1, 2]. The higher USA incidence of hypertension
is occupied by collagenous material and the tuft is retracted). (HTN)-associated ESRD may relate to its higher inci-
Results. Sixty-two patients (19 African Americans, 43 Cau- dence in African Americans. When compared with Cau-casians) were included in the study. At biopsy, African Ameri-
casians, African Americans show a disproportionate in-cans were younger than Caucasians with higher serum creati-
crease in the incidence of hypertensive ESRD in all agenine, but no difference in proteinuria or mean arterial pressure
(MAP). African Americans had a marked increase in the solidi- groups [2]. Several studies showed that this difference
fied form of GS (25  6 in African Americans vs. 8  2% in could not be explained by the higher prevalence and
Caucasians, P 0.01). This extensive solidification of glomeruli
greater severity of hypertension in African Americans,was associated with segmental sclerosis in African Americans
or by socioeconomic status or decreased access to health(38  10%), contrasting low prevalence of solidified GS in
Caucasians with segmental sclerosis (10  3%, P  0.05) and care [3, 4]. Despite similar blood pressure (BP) control,
in African Americans without segmental sclerosis (10  4%, African Americans with hypertension and renal insuffi-
P  0.05). African Americans with segmental sclerosis were ciency have a more rapid fall in renal function than
younger and clinically expressed a more severe renal disease
Caucasians [5, 6], suggesting that a lower level of BPthan Caucasians with this lesion. Interstitial fibrosis was greater
control may be even more important in African Ameri-in African Americans than in Caucasians (54  6 vs. 33  3%,
P 0.01) and correlated with proteinuria and serum creatinine cans than in Caucasians in slowing the progression of
levels, especially in African Americans, and also with GS. Vas- renal disease [7, 8]. Indeed, the recent update on the
cular sclerosis was worse in African Americans than in Cauca- AASK intervention trial showed that BP control withsians (0.96  0.04 vs. 0.77  0.08 score, P  0.05) and did not
angiotensin I converting enzyme (ACE)-inhibitor couldcorrelate with GS. By modeling, neither MAP nor age was
slow progressive loss of glomerular filtration rate (GFR)useful in predicting any morphological lesions and proteinuria
accounted only minimally for the variability of GS. in African Americans with hypertensive nephrosclerosis
[9]. Excess end organ damage in African Americans with
hypertension-associated nephrosclerosis has been associ-Key words: hypertension, race, global glomerulosclerosis, sclerosis le-
sions, progressive renal disease, end-stage renal disease. ated with genetically and/or environmentally induced
amplification of profibrotic mechanisms, such as the re-Received for publication July 30, 2001
nin angiotensin system (RAS) and transforming growthand in revised form February 5, 2002
Accepted for publication February 22, 2002 factor- (TGF-) [10–13].
Doubts continue to be expressed, however, about the 2002 by the International Society of Nephrology
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accuracy of the observation that hypertension is a com- All renal biopsy cases with this histological diagnosis
mon cause of ESRD: the clinical diagnosis of hyper- from the last 11 years in our division were identified.
tensive nephrosclerosis is much over-utilized, largely un- The diagnosis was made by light microscopy, and immu-
substantiated by biopsy or autopsy data. A recent study nofluorescence (IF) and/or electron microscopic (EM)
showed that hypertensive nephrosclerosis is less frequent examination. Renal biopsies were included in the analy-
in an ESRD population than commonly assumed if strict sis if five or more glomeruli were present in the tissue
clinical criteria are used, the prevalence changing from examined by light microscopy, and if the IF and/or EM
37% to 1.5-13% [14]. Such a misclassification bias might were available to exclude any immune deposits or other
be exaggerated in African Americans, who are more likely disease. Sixty-two renal biopsies met the criteria. Tissue
to be clinically labeled as having hypertensive renal dis- for both IF and EM was available in 48 (77%), for IF
ease than white patients [15]. Few patients with presumed but not EM in 2 (3%), and for EM but not IF in 12,
hypertensive nephrosclerosis undergo kidney biopsy. In with a total of 60 cases examined by EM.
a study of 56 consecutive Caucasian patients clinically The histological diagnosis of hypertensive nephroscle-
diagnosed as having hypertensive nephrosclerosis, renal rosis was made by standard morphological criteria, in-
biopsy determined that only 48% indeed had this lesion cluding sclerosis of vessels with extensive global glomer-
[16]. However, in the AASK pilot trial a very close agree-
ulosclerosis and proportional tubulointerstitial fibrosisment between clinical diagnoses based on careful screen-
in the absence of other defining lesions. Cases with seg-ing and biopsy findings of hypertensive nephrosclerosis
mental glomerulosclerosis were included when primarywas shown [17]. That study included African Americans
focal segmental glomerulosclerosis (FSGS) was excludedwith hypertension and moderate renal insufficiency who
by usual diagnostic criteria. These criteria include focalhad no marked proteinuria and no evidence of diabetes
and segmental glomerulosclerosis lesions with extensiveor other systemic illness. Of note, for ethical reasons no
foot process effacement, lack of disproportionately se-control population was included in the AASK biopsy study.
vere vascular lesions vis-a-vis glomerular lesions and theMarked proteinuria may occur in hypertensive neph-
presence of proteinuria, mostly in nephrotic range withrosclerosis, and has been a sign of poor prognosis [18, 19].
hypoalbuminemia and hyperlipidemia, at the onset ofDirect and indirect experimental and clinical evidence
renal disease. Criteria for diagnosis of secondary FSGSsupports a role of proteinuria in the development and
associated with hypertensive nephrosclerosis included,progression of sclerosis. What is not yet well defined is
in addition to the segmental sclerosis, the predominancewhether proteinuria is merely a marker of the vascular/
of small, shrunken, globally sclerotic glomeruli, the pres-glomerular/tubular derangements or whether it plays a
primary, key role in the causation of renal lesions in ence of periglomerular fibrosis, glomerular basement mem-
diseases such as interstitial diseases and hypertensive brane (GBM) corrugation, increased lucency of the lam-
nephrosclerosis, characterized by mild-to-moderate pro- ina rara interna and subtotal foot process effacement
teinuria and slow progression. by EM, and disproportionately severe vascular lesions
We therefore decided to examine retrospectively our relative to sclerosis. Other causes of secondary FSGS le-
clinical renal biopsies to qualitatively and quantitatively sions, such as reflux nephropathy, were excluded based
assess renal lesions in biopsied African Americans and on absence of morphological criteria that are suggestive
Caucasians who morphologically had hypertensive neph- of this entity (that is, patchy, geographical areas of fibro-
rosclerosis in the absence of diabetes or other systemic sis with disproportionate tubulointerstitial injury) and
illness. These patients underwent renal biopsy for clinical most importantly, an absence of a clinical history of uri-
indications, most commonly significant proteinuria or ele- nary tract infection (UTI) or pyelonephritis. Most impor-
vated serum creatinine. Clearly, in this retrospective study, tantly, biopsy findings were interpreted and correlated
clinical criteria for renal biopsy determined the study with a clinical course consistent with hypertensive neph-
population. Thus, we anticipated that African Americans rosclerosis for diagnosis. Thus, patients with hyperten-
would undergo renal biopsy only when clinical disease sive nephrosclerosis had hypertension preceding docu-
was more severe, due to the frequency of presumptive
mented presence of renal disease (that is, renal failure orclinical diagnosis of hypertensive nephrosclerosis in these
significant proteinuria). Conversely, none had significantpatients. In this population, we then investigated the rela-
proteinuria preceding development of hypertension.tionship of blood pressure, proteinuria and renal lesions,
Clinical information was obtained from questionnairesand further explored possible differences in these rela-
to referring clinicians and by chart reviews. Patients withtionships in African Americans versus Caucasians.
diabetes or other systemic diseases other than hyperten-
sion were excluded. In all case, the clinical history of
METHODS hypertension preceded the known onset of renal abnor-
Patient selection malities, such as proteinuria or renal insufficiency. Data
on the following parameters at the time of biopsy wasCases were selected based on clinical and morphologi-
cal diagnostic criteria of hypertensive nephrosclerosis. evaluated: history and known duration of hypertension,
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Table 1. Patient characteristics at biopsysystolic and diastolic BP, serum creatinine, proteinuria,
presence of hematuria, other organ evidence of hyper- All African Americans Caucasians P
tensive damage, family history of hypertension, and Patients N 62 19 43
Gender F/M 27/35 8/11 19/24 NSsmoking history.
Age years 58.72 50.54 62.32 0.01
SCr mg/dL 3.40.5 5.51.5 2.40.2 0.03Renal biopsy analysis
Uprot g/24 h 1.80.3 2.40.6 1.50.3 NS
MAP mm Hg 1053 1134 1052 NSAll slides were assessed without knowledge of any
% GS 423 505 394 NSclinical parameters. For each biopsy nine slides of serial
% ObsGS 293 245 314 NS
tissue sections stained with hematoxylin and eosin, peri- % SolGS 132 256 82 0.01
% SS 51 72 41.3 NSodic acid-Schiff (PAS) and Jones’ stains were examined.
% Int fibrosis 403 546 333 0.01IF and EM reports and prints were reviewed to exclude
V sclerosis 0.83 0.960.04 0.770.08 0.05
any cases with other concurrent diseases. The presence
Data are shown as mean  SE. Abbreviations are: SCr, serum creatinine;of global or segmental glomerulosclerosis (Fig. 1) was Uprot, proteinuria; MAP, mean arterial pressure; GS, global sclerosis; ObsGS,
obsolescent glomeruli; SolGS, solidified glomeruli; SS, segmental sclerosis; Intassessed and quantified as percentage of total number
fibrosis, interstitial fibrosis; V sclerosis, vascular sclerosis score (0 to 3 scale).of glomeruli for each biopsy. The globally sclerotic glo-
meruli were separated into three categories: obsolescent,
solidified or disappearing.
the ages of 30 and 75 years. This analysis validated the
inclusion of all patients for the subsequent analyses• Obsolescent glomeruli were defined as glomeruli in
which Bowman’s space was occupied by collage- (Results section).
Differences in average values of measurements werenous, PAS positive material, and the tuft was re-
tracted (Fig. 1) [20]. evaluated using the Wilcoxon rank sum test, accounting
for outliers in some variables including urinary protein• Solidified glomeruli were defined as glomeruli in
which the entire tuft was solidified, in the absence of and serum creatinine. Multiple linear regression was used
to assess the influence of urinary protein, mean arterialthe collagenous change in the capsular space (Fig. 1)
[21]. pressure, serum creatinine and age on morphological
variables. Logistic regression was used to assess differ-• Disappearing glomeruli were identified as globally
sclerotic glomeruli where there was an absence or ences in patients with or without segmental sclerosis,
which might be explained by urinary protein, mean arte-partial disappearance of Bowman’s capsule, which
in some cases extended to partial dissolution of the rial pressure, vascular sclerosis, or interstitial fibrosis.
globally sclerotic glomerulus, which then became
continuous with the fibrotic interstitium (Fig. 2).
RESULTS
Patient populationThe presence of mesangial expansion and hyalinosis
in the glomeruli was assessed. Periglomerular fibrosis, Sixty-two patients (19 African Americans and 43 Cau-
casians) met the inclusion criteria (Table 1). Femalesdefined as concentric arrangement of fibers around Bow-
man’s capsule, and reduplication of Bowman’s capsule and males were proportionally distributed in the two
race groups (27 F/35 M overall; 8/11 F/M among Africanwere assessed and expressed as percentage of total num-
ber glomeruli involved. Arterioles, interlobular and large Americans; 19/24 F/M among Caucasians; P  NS) and
in age class groups (P  NS). At biopsy, the averagearteries were assessed, and the extent and severity of
intimal fibrosis, medial thickness and hyalinosis (Fig. 1) age of the whole population was 58.7 2.0 years. African
Americans were younger than Caucasians. Mean serumwere scored semiquantitatively on a 0 to 3 scale, with
0  no lesions present, 1  mild, 2  moderate and creatinine was 3.4  0.5 mg/dL, significantly higher in
African Americans than in Caucasians. Urine protein3 severe, based on the average severity of all vessels.
Vascular sclerosis score was then calculated as average excretion was on average 1.8  0.3 g/24 h, similar in
African Americans and in Caucasians. MAP was notscore for intimal fibrosis, medial thickness and hyalinosis.
Tubular atrophy and interstitial fibrosis were assessed different between African Americans and Caucasians.
Male gender and African American race were associatedand semiquantified as percentage of the specimen involved.
with significantly higher serum creatinine versus other
Statistical analysis groups (P  0.04).
The family history was positive for hypertension inData are presented as mean  SE.
To examine whether there was a bias introduced by 21 of 43 patients for whom this information was avail-
able, with higher incidence in African Americans thanthe younger age (Table 1) of biopsied African Ameri-
cans versus Caucasians, we also separately analyzed an in Caucasians (70 vs. 40%). More African Americans
than Caucasians were smokers (information available inage parity subgroup consisting of all patients between
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45 patients, 70% African Americans vs. 45% Caucasians Mild-to-moderate hyalinosis of arterioles and interlobu-
lar arteries was found in 66% of the biopsies. The vascu-smokers). Hypertension preceded any urinary or kidney
function abnormalities in all cases, the exact known dura- lar sclerosis score was, on average, 0.83 (scale 0 to 3)
higher in African Americans than in Caucasians (0.96 tion of hypertension ranging from 2 to 30 years. Hyper-
tensive retinopathy was present in 36 patients: 12 African 0.04 vs. 0.77  0.08, P  0.05).
Periglomerular fibrosis was present in 29 biopsies in-Americans (range I to III Keith-Wagener classification)
and 24 Caucasians (range I to II Keith-Wagener classifi- volving on average 92% of all glomeruli in the involved
biopsies. Reduplication of Bowman’s capsule was pres-cation). Left ventricular hypertrophy was present in 35
patients (13 African Americans, 22 Caucasians). Serum ent in 26 biopsies, involving 71% of all glomeruli in these
biopsies. 30 biopsies showed evidence of disappearingcholesterol was available in 28 patients and on average
was 208  11 mg/dL (African Americans 195  16 vs. glomeruli, on average affecting 71% of the sampled glo-
meruli in these biopsies (Fig. 2).Caucasians 214  14 mg/dL).
Follow-up data on renal function was available in 23 The percent of global sclerosis, percent of interstitial
fibrosis and vascular sclerosis were not related to increas-of 62 patients (11 African Americans, 12 Caucasians),
with average follow-up time 23  5 months (range 1 to ing age, or male/female gender, although males numeri-
cally showed worse lesions.96 months). Of the 11 African Americans, 7 were on
hemodialysis (73%), one was near ESRD [serum creati-
Subgroup with segmental sclerosisnine (SCr) 8.1 mg/dL], and 3 patients were stable. Of
the 12 Caucasians, 2 were on hemodialysis (17%), 1 Twenty-one biopsies (Table 2) showed segmental scle-
rosis (Fig. 1D) with an overrepresentation of Africanwas near ESRD (SCr 7.8 mg/dL), 6 were stable and 3
had progressive increase in SCr, on average from 1.7  Americans (P  0.038), especially male African Ameri-
cans (P  0.02). However, the extent of glomeruli with0.2 mg/dL to 2.7  0.4 mg/dL.
segmental sclerosis within this subgroup with this lesion
Biopsy findings was not different in African Americans versus Cauca-
sians (13  2 vs. 15  3%, P  NS). Interestingly, inThe 62 biopsies contained, on average, 16  3 glo-
meruli. Cases by definition had EM and/or IF avail- African Americans with segmental sclerosis the per-
cent of solidified glomeruli was markedly higher thanable without any morphological evidence of additional
disease processes (Methods section). Thus, no immune in Caucasians with segmental sclerosis (38  10 vs. 10 
3%, P  0.01), and higher than in patients (either Afri-complexes were present in any of the cases by either IF
or EM. can Americans and Caucasians) without segmental scle-
rosis (Table 2). Conversely, very extensive solidified GSTotal global glomerular sclerosis was extensive, but
not statistically different between African Americans was associated with segmental sclerosis in African Ameri-
cans, contrasting low levels of solidified GS in Cauca-and Caucasians (all patients 42  3%; African Ameri-
cans 50  5% vs. Caucasians 39  4%, P  NS) and sians with and without segmental lesions, and in Afri-
can Americans without segmental lesions. Thus, theredid not increase with increasing age. Surprisingly, the
percent of solidified glomeruli (that is, globally sclerotic was a marked difference in global sclerosis phenotype
associated with segmental sclerosis between the twoglomeruli, in which the entire tuft is solidified, in the
absence of collagenous change in the capsular space; race groups.
The interstitial damage was much more severe in Afri-Fig. 1A) was significantly increased in African Ameri-
cans (all patients 13  2%; African Americans 25  6% can Americans with segmental sclerosis than in Cau-
casians with this lesion (65  8 vs. 43  7%, P  0.05)vs. Caucasians 8 2%, P 0.01). In contrast, the percent
of obsolescent glomeruli (that is, globally sclerotic glo- and than in African Americans and Caucasians with-
out segmental sclerosis (Table 2). Furthermore, Africanmeruli, in which Bowman’s space is occupied by collage-
nous material and the tuft is retracted, Fig. 1B) was not Americans with segmental sclerosis were younger than
Caucasians with this lesion (African Americans 44.3 different between African Americans and Caucasians
(all patients 29  3%; African Americans 24  5% vs. 5.0 vs. Caucasians 65.0  3.8 years, P  0.03), and they
clinically expressed a more severe renal disease. MAPCaucasians 31  4%, P  NS). Further, the percent of
solidified glomeruli did not increase with aging, while (121  5 in African Americans vs. 107  3 mm Hg in
Caucasians, P  0.03), proteinuria (3.4  0.9 in Africanthe percent of obsolescent glomeruli did.
Interstitial fibrosis was significantly greater in African- Americans vs. 1.4  0.4 g/24 h in Caucasians, P  0.05)
and serum creatinine (5.4 1.6 in African Americans vs.Americans than in Caucasians (all patients 40  3%;
African Americans 54  6 vs. Caucasians 33  3%, 3.0  0.5 mg/dL in Caucasians, P  0.05) were higher
in African Americans with segmental sclerosis than inP  0.01).
All the biopsy cases, by definition, showed the pres- Caucasians with this lesion.
Since the Caucasian patients were significantly olderence of arteriolosclerosis and/or arteriosclerosis (Fig. 1C).
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Fig. 1. Lesions in hypertensive nephrosclerosis. Global glomerulosclerosis was categorized as either the solidified type (A), with solidification of
the glomerular tuft, or the obsolescent type (B) with global sclerosis with retraction of the tuft and Bowman’s space occupied by collagenous
material. Vascular sclerosis was manifest by medial hypertrophy and intimal fibrosis (C ). Segmental sclerosis (D) was present more frequently in
association with solidified global glomerulosclerosis (A, B, D, Jones’ silver stain, 400; C, periodic Acid Schiff stain, 400):
Fig. 2. “Disappearing” glomeruli in hypertensive nephrosclerosis. Some globally sclerotic glomeruli show dissolution of Bowman’s capsule, with
a continuum of the sclerotic glomerulus and the fibrotic interstitium, which ultimately leads to disappearance of a recognizable glomerular tuft
(A,B, Jones’ silver stain, 400).
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Table 2. Biopsy findings in the different patient groups
Without segmental sclerosis With segmental sclerosis
African African
All Americans Caucasians All Americans Caucasians
Patients N 41 9 32 21 10 11
Age years 60.52 57.45 61.42.4 554 44.35 653.8a
SCr mg/dL 2.90.7 5.62.7 2.20.2 4.20.8 5.41.6 30.5a
Uprot g/24 h 1.50.3 1.20.3 1.60.4 2.40.6 3.40.9b 1.40.4a
MAP mm Hg 1013 1044 1004 1133 1215b 1073a
% GS 404 478 385 465 577 378
% ObsGS 324 367 315 234 185 276
% SolGS 82 104 72 247 3810b 103a
% SS 0 0 0 152 132 153
% Int fibrosis 324 429 304 535 658b 437a
V sclerosis 0.80 0.900.4 0.77 0.88 0.930.1 0.8501
Data are shown as mean  SE. Abbreviations are: SCr, serum creatinine; Uprot, proteinuria; MAP, mean arterial pressure; GS, global sclerosis; ObsGS, obsolescent
glomeruli; SolGS, solidified glomeruli; SS, segmental sclerosis; Int fibrosis, interstitial fibrosis; V sclerosis, vascular sclerosis score (0 to 3 score).
a P  0.05 vs. African Americans with segmental sclerosis
b P  0.05 vs. African Americans without segmental sclerosis
Table 3. Multiple linear regression modeling of morphologic lesionsthan the African Americans, we also performed the above
by clinical parameters
analyses in only those 50 patients who could be matched
R2 P Uprot MAP SCr Agefor age (equi-age subgroup analysis) to validate the anal-
GSyses that include all patients of all ages. This group in-
All 0.16 0.05 0.01 NS NS NScluded 17 African Americans and 33 Caucasians with an
African Americans NS NS NS NS NS NS
average age of 54 4 years in African Americans versus Caucasians NS NS NS NS NS NS
% Obs sclerosis57  2 years in Caucasians (P  NS). Thus, the two
All NS NS NS NS NS NSAfrican Americans younger than age 30 years, and the
African Americans NS NS NS NS NS NS
10 Caucasians older than 75 years were excluded from Caucasians NS NS NS NS NS NS
% Sol GSthis analysis. None of the above results were altered in
All 0.29 0.001 NS NS 0.007 0.03this age-matched group of 50 patients, except that the African Americans NS NS NS NS NS NS
more severe vascular sclerosis in African Americans Caucasians NS NS NS NS NS NS
% SSversus Caucasians now reached statistical significance
All 0.22 0.01 NS NS 0.002 NS(0.98  0.08 vs. 0.74 0.29, P 0.02). The below analy- African Americans 0.51 0.03 0.01 NS 0.03 NS
ses therefore include the entire age range of patients. Caucasians NS NS NS NS NS NS
% Int fibrosis
All 0.38 0.0001 0.02 NS 0.0001 NSClinical pathological correlations
African Americans 0.64 0.004 0.003 NS 0.008 NS
Caucasians NS NS NS NS NS NSA multiple linear regression analysis was performed to
V sclerosisexamine if the clinical parameters of proteinuria, MAP,
All 0.16 0.05 NS NS 0.007 NS
serum creatinine and age could predict the severity of African Americans NS NS NS NS NS NS
Caucasians 0.27 0.03 NS NS 0.01 NSstructural injury observed (Table 3). This model was
Data are shown as mean  SE. Contributors to the model are indicated bystatistically significant for the lesions of total global scle-
specific P value where the overall model was statistically significant, or indicatedrosis, segmental glomerulosclerosis, vascular sclerosis as not significant. Abbreviations are: NS, not significant; SCr, serum creatinine;
Uprot, proteinuria; MAP, mean arterial pressure; GS, global sclerosis; ObsGS,and interstitial fibrosis. However, total global sclerosis
obsolescent glomeruli; SolGS, solidified glomeruli; SS, segmental sclerosis; Intand vascular sclerosis were poorly predicted by this fibrosis, interstitial fibrosis; V sclerosis, vascular sclerosis score (0–3 scale).
model (R2  0.16). The model did not account for the
obsolescent type of global sclerosis, but could predict
solidified glomeruli. Further, the individual components
creatinine both contributed significantly to this predic-of the model were analyzed. MAP did not contribute to
tion in African Americans.the prediction by the model of any morphologic lesions.
Age did not account for any morphological lesions,Proteinuria accounted only minimally for the variability
except for an overall model effect on solidified GS. How-of global glomerulosclerosis, but had better predictive
ever, logistic regression analysis did not show a directvalue for the segmental sclerosis in African Americans
correlation of solidified glomerulosclerosis with aging.only: this result was confirmed by logistic regression anal-
In contrast, a stepwise increase of obsolescent type glo-ysis. The total model accounted for interstitial fibrosis
somewhat better (R2  0.38) and proteinuria and serum merulosclerosis was seen with increasing age.
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In summary, in this study, age and blood pressure were versus Caucasians, implicating different mechanisms may
contribute to the development of the lesions.not good predictors of severity of structural injuries. Pro-
Heptinstall has described two distinct populations ofteinuria was strongly related to segmental sclerotic lesions
globally sclerotic glomeruli in essential hypertension: (1)and interstitial fibrosis only in African Americans.
the obsolescent glomerulus, characterized by collage-
Pathological correlations nous material filling the capsular space and retraction of
the tuft; and (2) the solidified glomerulus, characterizedInterstitial fibrosis correlated with total global sclero-
by solidification of the tuft, without collagenous changesis, both in African-Americans and Caucasians (Spear-
in the capsular space [22]. In his own extensive experi-man correlation, r 0.59, P 0.0001), and with segmen-
ence, the first type was much more common, especially intal sclerosis, as shown also by logistic regression analysis
older patients (race was not specified). This lesion was(P 0.01), only in African Americans (Spearman corre-
traditionally regarded as the consequence of ischemialation, r  0.48, P  0.03). Vascular sclerosis did not
from the commonly noted association of glomerularcorrelate with global and segmental glomerulosclerosis.
changes with narrowing of the intrarenal vasculature.To better define the association of solidification with
However, neither experimental nor human studies eluci-segmental sclerosis, two morphological groups of the pop-
dated the pathogenesis or precursor lesion(s) of theseulation were then compared: those with segmental scle-
two distinct forms of global sclerosis. From our experi-rosis and solidified glomeruli (N  15) to those without
ence, it is likely that the solidified glomerulus is globallythese lesions (N  16). Logistic regression showed that
sclerotic from the start and that the two phenotypes ofthese groups could be distinguished by the presence of
sclerosis are independent phenomena. It is difficult tomore severe vascular sclerosis in the former (P  0.03).
hypothesize that the solidified glomerulus derives fromThe morphologic lesions in African Americans versus
an obsolescent stage. This would imply that there was aCaucasians were then compared by logistic regression.
complete resorption of the collagen filling Bowman’sThese two populations could be distinguished by the
space. We therefore conclude that the differences in phe-presence of more severe interstitial fibrosis in the former
notype of glomerular sclerosis in our study cannot be
(P  0.05).
accounted for by differences in time point of biopsy.
Our data showed a trend of increasing glomerular ob-
solescence with aging, suggesting that it could be a pro-DISCUSSION
cess associated with normal aging. In contrast, extensiveThis study confirms the greater severity at biopsy of
glomerular solidification was significantly associated withhypertensive nephrosclerosis in African Americans com-
segmental sclerosis, particularly in African Americans.pared to Caucasians. As shown elegantly by Perneger
This observation suggests a possible different mechanismet al [15], the clinical presumption that a patient has
in the progression of glomerular sclerosis in hypertensivehypertensive nephrosclerosis as their underlying renal
nephrosclerosis between African Americans and Cauca-
disease is much more strongly held for African American
sians. We speculate that the association of segmental
versus Caucasian patients with renal disease. Further sclerosis with severe glomerular solidification in African
evidence that the biopsy patterns include only those Afri- Americans suggests these lesions could be pathogenet-
can American patients with evidence of more severe ically related. Logistic regression showed that patients
renal disease was that the biopsies were performed at with segmental glomerulosclerosis and solidified glomer-
significantly higher serum creatinine values in this sub- uli could be distinguished from those without these le-
group (5.5  1.5 mg/dL vs. 2.4  0.2 mg/dL in Cauca- sions by the presence of more severe vascular sclerosis
sians). These differences cannot be accounted for by in the former. We speculate that solidified glomeruli may
age, since African Americans were more than a decade originate from a vasospasm/functional vasoconstriction in
younger than Caucasian patients. Thus, as we had antici- those African American patients with higher blood pres-
pated, it is possible that our study population reflects sure and more severe reactivity of glomeruli and vessels
differences in clinical biopsy indications and that African to hypertension. African Americans tend to show a larger
Americans were biopsied at a later, more severe stage increase in blood pressure level than Caucasians during
of disease. However, the striking qualitative difference stress, particularly to stimuli that elicit a vasoconstrictor
in the sclerosis phenotype between the two groups, with response, such as submaximal dynamic exercise or cold
African Americans showing marked increase of the so- face stimulus [23–25]. Normotensive young African Amer-
lidified form of global glomerular sclerosis, especially icans males in one study showed significantly greater
associated with segmental sclerotic lesions, is indepen- minimum forearm vascular resistance than normoten-
dent from the clinical biopsy practice and the time point sive young Caucasian males, suggesting that there is a
of biopsy. These findings point to quantitative as well as structural difference in the resistance vessels in these
two populations [26]. Further, African Americans andqualitative differences in sclerosis in African Americans
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Caucasians may have different diurnal blood pressure of their blood supply” [33]. Our data from the current
rhythms, with African Americans showing smaller differ- study, the AASK biopsy data and such observations thus
ences between waking and sleeping blood pressure val- point to other mechanisms of lesions in patients with
ues [27]. Evidence from other studies has supported that hypertension-associated renal disease.
autoregulatory response to hypertension, resulting in va- The role of proteinuria, a known risk factor for devel-
sospasm, could be excessive in patients susceptible to opment and progression of sclerosis, also was examined
develop hypertension, like some African Americans [28]. in our study. By modeling, proteinuria accounted mini-
Thus, we speculate that global vasoconstrictive ischemia mally for the variability of global glomerulosclerosis in
could result in complete collapse and solidification. Fur- all patients and correlated with segmental sclerosis and
ther, we hypothesize that adaptation and segmental resis- interstitial damage only in African Americans, and not
tance to collapse and/or reflow, with possible attendant in Caucasians. These data do not support a major role
segmental hypertension/hyperfiltration, could give rise to for proteinuria in causality of the lesions, at least not in
segmental sclerotic lesions associated with solidification Caucasians. Thus, proteinuria is not pivotal in develop-
in those patients. Thus, vasospasm could reflect a primary ment and progression of sclerosis in all renal diseases
microvascular injury and endothelial dysfunction that [34]. We cannot exclude that proteinuria can affect the
causes hypertension, or occurs in response to hyperten-
severity of some lesions, but this relationship was seension, in susceptible patients. Hence, it is possible that a
only in African Americans. The higher proteinuria inprimary renal microvascular disease results in hyperten-
this subgroup may be a marker of a severe primary un-sion, glomerulosclerosis and interstitial fibrosis [4].
derlying microvascular disease in African Americans, orOf note, in our study the extent of tubular atrophy
alternatively may contribute to vascular and/or tubularand interstitial fibrosis was higher in African Ameri-
injury directly or indirectly. However, our conclusionscans, particularly those with segmental sclerosis, than in
are limited by the retrospective nature of the study, inCaucasians. These data could reflect again an increased
that our clinically indicated biopsies greatly over-repre-reactivity of this subgroup of African Americans with
sent patients with significant proteinuria. Thus, we maysegmental sclerosis in which an excessive ischemic vaso-
not have been able to detect a differential effect of pro-constriction results in glomerular solidification and re-
teinuria on the total spectrum of the disease process.lated tubulointerstitial lesions because of reduced post-
In summary, this study confirms the greater severity ofglomerular circulation. The strong correlation between
interstitial fibrosis and global glomerulosclerosis sup- hypertensive nephrosclerosis in biopsied African Amer-
ports this hypothesis. This postulate is also favored by icans compared to Caucasians. Blood pressure levels and
studies of Fine et al, who recently hypothesized that proteinuria did not account for morphological lesions,
ischemia and chronic oxygen deprivation may contribute suggesting that other factors (for example, genetic fac-
to initiate and maintain the fibrogenic cascade in the tors, primary microvascular diseases) may play a role.
renal interstitium. Indeed, cultured human renal micro- Further, our study points to qualitative differences in
vascular endothelial and proximal tubular cells and inter- phenotype of glomerulosclerosis in these groups. The so-
stitial fibroblasts showed a fibrogenic response to hyp- lidified form of global glomerulosclerosis, especially as-
oxia [29, 30]. Recent data from Johnson et al have sociated with segmental sclerotic lesions, was much more
focused on peritubular capillaries as possible key initia- common in African Americans, suggesting different
tors for progressive renal disease [31, 32]. The severe mechanisms may contribute to the development and pro-
interstitial fibrosis seen in the biopsies in this study sup- gression of glomerulosclerosis in African Americans ver-
port that these capillaries could contribute to injury and
sus Caucasians. We speculate that solidified glomeruliinitiate and/or perpetuate hypertension.
may originate from an excessive autoregulatory responseHowever, our data do not support any relationship
in susceptible patients like African Americans, and thatof causality: whether vascular, glomerular or interstitial
obsolescent glomeruli reflect a milder mechanism of in-lesions account for the initiation of renal progressive dis-
jury, likely associated with aging. These findings furtherease remains unclear. Further, our results do not support
show a morphological basis to support that differentthe direct causal relationship expected by the term “hy-
treatment strategies and blood pressure goals, as evi-pertensive nephrosclerosis,” namely that hypertension
denced in the AASK trial [9], may be indicated for Afri-causes vascular sclerosis that in turn causes global glo-
can Americans versus Caucasians with hypertension-merulosclerosis. Indeed, by modeling, blood pressure
associated renal insufficiency.values did not account for any morphological lesions and
vascular sclerosis lesions did not correlate with extent
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C3310, Department of Pathology, Vanderbilt University Medical Center,
noted that blood vessels in benign nephrosclerosis “do Nashville, Tennessee 37232-2561, USA.
E-mail: agnes.fogo@mcmail.vanderbilt.edunot show the type of lesions which deprives nephrons
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